A Phase IV, Randomized, Open-Label, Parallel-Arm, Comparative and Forced- Titration Study to Compare the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Patients With Type 2 DM [diabetes mellitus] and Dyslipidemia.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Rosuvastatin; Simvastatin
- Indications Dyslipidaemias
- Focus Therapeutic Use
- 06 Dec 2011 Biomarkers information updated
- 26 Jun 2009 Actual patient number (90) added as reported by ClinicalTrials.gov.
- 26 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.